Sanofi Aventis SA

  • 12 Jan 2007

Rating:A1/AA-/AA-
Amount:£200m
Maturity:18 January 2010
Issue/re-offer price:99.694
Coupon:5.5%
Spread at re-offer:37bp over Gilts
Launch date: Thursday 11 January
Payment date:18 January
Sole mgr: HSBC

Bookrunner's comment:

Sanofi Aventis is the world's third largest pharmaceutical company with over Eu27bn in revenues. This is its inaugural sterling transaction.

We set the price talk at 37bp-39bp over Gilts and with significant demand from high ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 JPMorgan 27.39 116 7.94%
2 Citi 26.63 85 7.72%
3 BofA Securities 20.17 73 5.85%
4 BNP Paribas 19.63 66 5.69%
5 HSBC 19.56 72 5.67%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 60.87 123 14.06%
2 Credit Agricole CIB 28.59 93 6.60%
3 Santander 25.41 90 5.87%
4 JPMorgan 23.88 61 5.52%
5 UniCredit 21.51 103 4.97%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 Morgan Stanley 0.94 4 13.47%
2 Goldman Sachs 0.78 5 11.09%
3 Credit Suisse 0.67 3 9.64%
4 HSBC 0.61 3 8.77%
5 BofA Securities 0.61 2 8.70%